Inhaled Amikacin for Treatment of Refractory Pulmonary Nontuberculous Mycobacterial Disease

Rationale: Treatment of pulmonary nontuberculous mycobacteria, especially Mycobacterium abscessus, requires prolonged, multidrug regimens with high toxicity and suboptimal efficacy. Options for refractory disease are limited. Objectives: We reviewed the efficacy and toxicity of inhaled amikacin in p...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Olivier, Kenneth N., Shaw, Pamela A., Glaser, Tanya S., Bhattacharyya, Darshana, Fleshner, Michelle, Brewer, Carmen C., Zalewski, Christopher K., Folio, Les R., Siegelman, Jenifer R., Shallom, Shamira, Park, In Kwon, Sampaio, Elizabeth P., Zelazny, Adrian M., Holland, Steven M., Prevots, D. Rebecca
Format: Artigo
Langue:Inglês
Publié: American Thoracic Society 2014
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3972984/
https://ncbi.nlm.nih.gov/pubmed/24460437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201307-231OC
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires